A seven-year-old male neutered Irish setter was treated for a metastatic anal sac adenocarcinoma (ASAC) and hypercalcaemia by complete surgical excision of the primary tumour and partial excision of the sublumbar lymph nodes. Further enlargement of the sublumbar lymph nodes was linked to recurrent hypercalcaemia 3 months after surgical treatment. Medical treatment with Toceranib and Clodronate showed modest results in the treatment of the tumour and the hypercalcaemia. Radiotherapy of the sublumbar lymph nodes and later concurrent carboplatin chemotherapy resulted in partial tumour remission with marked reduction in size of the lymph nodes and normalization of the calcaemia. Unfortunately, concurrently with subsequent relapse of the hypercalaemia, the dog developed hypertrophic osteopathy (HO) and lumbar spinal metastasis and the dog was euthanized. To the authors' knowledge, this is the second case of metastatic apocrine gland carcinoma of the anal sac associated with HO and the first case that describe the development of HO late in the stage of the disease.
Introduction
Anal sac carcinoma is a relatively uncommon neoplasia in dogs that originates from the apocrine glands of the anal sac (Withrow, 2001) . Anal sac carcinoma is an aggressive tumour with a tendency to metastasise to sublumbar lymph node and later to liver and lungs. Paraneoplastic hypercalcaemia is relatively common occurring in 25-53% of cases, often complicating the clinical management of the affected patients (Ross et al., 1991; Bennett et al., 2002; Williams et al., 2003) . Hypertrophic osteopathy (HO) is characterized by the deposition of periosteal new bone mainly in the distal appendicular skeleton. In people, HO is mainly associated with pulmonary diseases, usually cancer (Carroll and Doyle, 1974) . In dogs, HO has been described in both neoplastic and non-neoplastic conditions affecting mainly the thoracic cavity. However it has also been described in association with tumours of the bladder, liver esophagus and nonneoplastic conditions (Mather and Low, 1953; Brodey, 1971; Halliwell and Ackerman, 1974; Hesselink and van den Tweel, 1990; Wylie et al., 1993; Watrous and Blumenfeld, 2002; Makungu et al., 2007; Lee et al., 2012; Salyusarenko et al., 2013; Withers et al., 2013) . In a recent review of HO in dogs it was found that all the patients had pulmonary nodules in the lungs, two were primary pulmonary tumours and 28 were metastasis. The most common histological type of metastatic tumour was osteosarcoma, but other tumour types were present in particular; bladder transitional cell carcinoma, prostatic carcinoma, renal carcinoma, renal adenocarcinoma with osteosarcomatous differentiation, chondrosarcoma, fibrosarcoma and leiomyosarcoma (Withers et al., 2013) . The pathogenesis of HO is not completely understood; but was thought to be an increase in the peripheral vascular supply to the periosteum due to stimulation of nerve fibers that innervate vascular tissue directly related to the pharyngeal and vagus nerves (Carroll and Doyle, 1974) . More recently, it has been proposed that the release of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) from platelets, due to abnormal platelet circulation could be involved in HO (Dickinson and Martin, 1987; Martinez-Lavin, 2007) .
Case Details A seven-year-old male neutered Irish setter was presented for severe polyuria and polydipsia and the suspicion of an anal sac tumour on the left side. Physical examination revealed a mass in the left anal gland. Haematology was unremarkable and biochemistry revealed moderate increase in total calcium, 3.94 mmol/L (ref range 2.15-2.72). The rest of the biochemistry was unremarkable. Thoracic radiographs were performed which revealed two small pulmonary nodules (1 and 0.66 cm in size) that were suspicious of metastatic spread. Abdominal radiographs showed a marked sublumbar soft tissue opacity. Abdominal ultrasound revealed marked left sublumbar (most likely medial iliac) lymphadenopathy. Haematology was unremarkable and biochemistry A. Giuliano et al. Open Veterinary Journal, (2015) , showed severe hypercalcaemia with an ionised calcium of 2.08 mmol/L (reference range, 1.18-1.4) with no other significant abnormalities detected. Fine needle aspirate of the left anal sac mass was not performed in view of the very typical presentation for an anal sac tumour. After saline (0.9%) fluid therapy at four times maintenance rate, oral clodronate 400 mg and a single subcutaneous injection of 6 mg dexamethasone, the hypercalcaemia almost resolved, (ionized calcium= 1.48mmol/L) and surgery was performed. The left anal sac mass and ipsilateral medial iliac lymph node were removed resulting in post-operative normocalcaemia. Histopathology of the mass confirmed anal sac carcinoma with metastatic spread to the lymph node. The decision was made to monitor the patient and re-examine in the following three months. In the meantime, total calcium levels were checked monthly by the referring veterinary surgeon. Three months after surgery, the dog presented with polyuria and polydipsia. An abdominal ultrasound confirmed the recurrence of metastatic carcinoma with marked sublumbar lymphadenopathy. Ionised calcium was elevated again. Treatment with toceranib 2.5 mg/kg every other day and clodronate 11 mg/kg twice a day was initiated. The dog achieved partial remission with reduction in size of the sublumbar lymph nodes and normocalcaemia. Toceranib was well tolerated with only mild neutropenia as side effect, which was controlled by reducing the dose of toceranib to every third day. Unfortunately, the patient developed hypercalcaemia again after two months and thoracic and abdominal radiographs showed marked enlargement of the sublumbar lymph nodes. The two pulmonary nodules that were seen in previous examination were similar in size (Fig. 1a) . Abdominal ultrasound revealed marked enlargement of the sublumbar lymph nodes, the rest of the abdomen was unremarkable and the dog had no other lymphadenopathy to suggest an alternative diagnosis of lymphoma. After discussion with the owner the decision was made to irradiate the sublumbar lymph nodes as a palliative treatment in the attempt to reduce hypercalcaemia and to restore a good quality of life. Two coarse fractions of 800 centigrays (cGys) radiation were administered 7 days apart via a parallel opposed beam configuration (400 cGys from right and left portals). Clodronate treatment was continued and toceranib was stopped. The radiotherapy resulted in reduction in size of the sublumbar lymph nodes and normocalcaemia. Hypercalcaemia was noticed again one month later in combination with further enlargement of the sublumbar lymph nodes. Another two fractions of radiotherapy were administered in combination with carboplatin 300 mg/m² every three weeks. The chemo-and radiotherapy resulted again in reduction in size of the sublumbar lymph nodes and restoration of normocalcaemia without clodronate treatment. Two months later, the patient again developed hypercalcaemia with severe increase in size of the sublumbar lymph nodes. On physical examination, the dog was lame in all four limbs and reluctant to stand up. All four distal limbs were swollen and painful on palpation. Thoracic and abdominal radiographs, abdominal ultrasound and radiographs of the appendicular long bones were performed. Previous pulmonary nodules had mildly increased in size to 2 and 1.6 cm and a few small new nodules were present as well (Fig. 1b) . Radiographs and ultrasound of the caudal abdomen revealed marked sublumbar lymphadenopathy and local invasion of the lumbar vertebrae. No other abdominal abnormalities were found (Fig. 2a and b) . Radiographs of the distal long bones had a palisading periosteal reaction, with the typical appearance of HO ( Fig. 3a and b) . Due to the extension, the lack of control of the disease and the development of HO, the patient was euthanized. Discussion In many ways this case is typical of anal sac adenocarcinoma (ASAC), a tumour that classically metastasizes early in the course of the disease with 79% of cases having sublumbar metastases at time of presentation and frequently associated with paraneoplastic hypercalcaemia in 25-53% of cases (Ross et al., 1991; Bennett et al., 2002; Williams et al., 2003) . The unusual feature of this case is the development of HO, relatively late in the course of the disease, without a significant radiographically detectable progression of the existing pulmonary pathology. The pulmonary nodules were initially assumed to be metastases from the ASAC, as the dog had no history or evidence of concurrent malignant disease. The slow progression of the nodules were considered to be consistent with the documented behaviour of this ASAC (Jeffery et al., 2000; Polton and Brearley, 2007) but a post mortem examination was not performed to confirm this to be the case. Giuliano et al. Open Veterinary Journal, (2015) , Vol. 5(1): [48] [49] [50] [51] The main challenge in the management of this case was the recurrence of the metastases in the sublumbar lymph nodes with a concomitant hypercalcaemia. Control of the tumour and the nodal metastases resulted in normalization of the calcaemia. Oral bisphosphonate (clodronate) was preferred to injectable biphosphonate in this case due to the good clinical condition of the dog and the resolution of the hypercalcaemia after tumour control. Surgical resection is the treatment of choice for ASAC and as shown in this case, surgical resection of metastatic sublumbar nodes is possible and can restore normocalaemia. The value of adjunctive treatment is debatable with some patients achieving long term survival with only surgery (Hobson et al., 2006) . Post-operative RT may be used at primary site where completeness of excision is uncertain, although the proximity to anus can lead to potential complications. The value of chemotherapy in prevention and management of metastatic disease is less well defined, but treatment with both carboplatin and mitoxantrone have been reported (Polton and Brearley, 2007) , as has melphalan (Emms, 2005) . More recently, toceranib has been reported to achieve clinical benefit in 28/32 dogs with ASAC (London et al., 2012) . HO has been described in numerous reports mainly associated with an extensive mass in the chest, or diffuse cancerous or non-cancerous pathology affecting the lungs; this is only the second report of HO in a dog with anal sac carcinoma (Hammond et al., 2009 ). This case is of interest due to the fact that the dog did not have extensive pulmonary pathology, or any respiratory signs. The two small nodules present on initial presentation did not cause initially any signs of HO and the few small new nodules visible on the last thoracic radiograph were considered unlikely to be the cause of the HO. The dog had also suffered from significant and recurrent sublumbar lymphadenopathy, during the course of his treatment, so this also seems unlikely to be the cause or trigger of HO. No other abdominal lesions were noted on ultrasound examination. It has been reported that there is no consistent radiografhical finding regarding location, number and size of the pulmonary nodules (Withers et al., 2013) . Therefore, it was reasonable to think that a mild increase in number and size of the nodules in the chest would not be, although possible, a reasonable explanation of the HO. It is interesting to note that the HO developed three months after toceranib was stopped. This drug is a selective inhibitor of VEGF and PDGF receptors. Recent publications have proposed a connection between increases these two growth factors in the periosteum and HO (Dickinson and Martin, 1987; Martinez-Lavin, 2007) . The administration of toceranib could have bound the VEGF and PDGF receptors in this case, causing a delay in the appearance of the HO which only became evident after withdrawal of the drug.
In conclusion, this is the second reported case of metastatic apocrine gland carcinoma of the anal sac associated with HO and unusually describe the development of HO very late in the stage of the disease. 
